Glucotrack (GCTK) Total Non-Current Liabilities (2012 - 2025)
Glucotrack's (GCTK) quarterly Total Non-Current Liabilities came in at $5.0 million in Q4 2025, up 231.5% YoY from $1.5 million in Q4 2024, and down 9.52% on a QoQ basis from $5.5 million in Q3 2025.
Glucotrack (GCTK) Total Non-Current Liabilities (2012 - 2025) Analysis & Trends
Glucotrack (GCTK) has 14 years of Total Non-Current Liabilities data on file, last reported at $5.0 million in Q4 2025.
- Quarterly Total Non-Current Liabilities rose 231.5% year-over-year to $5.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.0 million (up 231.5% YoY) and the FY2025 annual result came in at $5.0 million, up 231.5% from the prior year.
- Total Non-Current Liabilities eased to $5.0 million in Q4 2025, from $5.5 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $5.5 million in Q3 2025 to a low of $184000.0 in Q3 2023.
- A 5-year average of $1.6 million and a median of $235000.0 in 2021 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2021 — Total Non-Current Liabilities sank 42.54% — and 2024, when it jumped 2514.67%.
- Tracing GCTK's Total Non-Current Liabilities over 5 years: stood at $227000.0 in 2021, then declined by 14.1% to $195000.0 in 2022, then soared by 675.38% to $1.5 million in 2023, then retreated by 0.07% to $1.5 million in 2024, then jumped by 231.5% to $5.0 million in 2025.
- The last three Total Non-Current Liabilities figures came in at $5.0 million (Q4 2025), $5.5 million (Q3 2025), and $3.3 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 48.34 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 6.34 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 985.45 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 17.56 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 996.30 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 8.96 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 3.98 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 12.41 Bn |
| 10 | Glucotrack | 1.68 Mn | 553,542.53 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.01 Mn |
| Sep 30, 2025 | 5.54 Mn |
| Jun 30, 2025 | 3.33 Mn |
| Mar 31, 2025 | 2.18 Mn |
| Dec 31, 2024 | 1.51 Mn |
| Sep 30, 2024 | 4.81 Mn |
| Jun 30, 2024 | 3.71 Mn |
| Mar 31, 2024 | 1.54 Mn |
| Dec 31, 2023 | 1.51 Mn |
| Sep 30, 2023 | 184,000.00 |
| Jun 30, 2023 | 189,000.00 |
| Mar 31, 2023 | 193,000.00 |
| Dec 31, 2022 | 195,000.00 |
| Sep 30, 2022 | 191,000.00 |
| Jun 30, 2022 | 192,000.00 |
| Mar 31, 2022 | 212,000.00 |
| Dec 31, 2021 | 227,000.00 |
| Sep 30, 2021 | 234,000.00 |
| Jun 30, 2021 | 236,000.00 |
| Mar 31, 2021 | 231,000.00 |